aTyr Pharma, Inc. (NASDAQ:ATYR) Faces Market Challenges Despite Promising Developments
aTyr Pharma, Inc.(US:ATYR) Financial Modeling Prepยท2025-09-16 02:05Derek Archila from Wells Fargo set a price target of $1 for aTyr Pharma, Inc. (NASDAQ:ATYR), indicating a cautious outlook.The announcement of the Phase III EFZO-FIT study results for Efzofitimod in pulmonary sarcoidosis marks a significant milestone for the company.aTyr Pharma's stock has experienced a dramatic decrease of 83.17%, highlighting the volatility and challenges in the biotech sector.aTyr Pharma, Inc. (NASDAQ:ATYR) is a biotechnology company focused on developing innovative medicines for patient ...